David Sims is the managing member of RidgeHaven Capital LLC. We prefer distressed equities and value investing. The firm was established to manage wealth with an eye on fundamental value, but also an understanding of technical trends and market behavior.
David is a Certified Public Accountant and previously worked as an auditor at a Big 4 accounting firm, SEC Reporting Analyst and financial systems administrator at a small private company.
Find the Sims On Finance Investing Podcast on iTunes, Tune In Radio, and Player FM radio.
Currently the President & CEO of a publicly traded startup in the temporary staffing industry, specifically what we call the "On-Demand" sector. I have been in the staffing industry for approx 14 years. I started out as an Account Executive for the largest on-demand provider in the country and have been in the staffing industry ever since.
Enjoy spending time with my wife and 3 beautiful children when Im not working. Doesn't have to be anything fancy, a day at the movies or at the park works just fine for me.
I have fourteen years of investment experience, investing in both Equity and Credit securities. I consider myself a generalist, but have deep knowledge of Healthcare, Consumer, and Telecom/Media.
Robotic Stock Trader Has a Global Team in place to help spread the word that robotic trading is here to stay, In today’s market place the days whereby you can invest in a company and hold on to your investments for decades. In today’s Boom and Bust economy it’s about taking profit every chance we get just like the pros.
I have a diverse background—as a financial journalist, resident physician, mixed martial artist, painter, entrepreneur, chemistry instructor and web developer—that enabled me to pioneer the “Integrated Investing Research” approach.
I provide consulting to clients, both the retail and professional investors. I accurately forecasted many clinical trials, such as the Flint Trials for Intercept, the Ascend Trials for InterMune and the Affinity Trials MannKind, just to name a few. Through Vincata Enterprises, LLC, I helped many clients to unlock substantial values for their investments.
As an expert in biopharmaceutical analysis, I am also more than capable of analyzing any other industries. Though not shown on Seeking Alpha, I have picked an aggregate basket of outperforming stocks.
Investing in biotech is highly risky, but it can be quite rewarding when investors have an edge in data analysis. Physicians who are rigidly scientific tend to lack the analytical prowess of financial experts. Conversely, financiers usually do not possess a physician’s medical expertise. Likewise, scientists are skillful in data analysis; yet they might not be familiar with a physician’s prescribing patterns, which is a requisite to successful biotech investing.
You can visit my website at https://www.retailinvestor360.com for business inquiry.
Investment professional and CFA charterholder. I write on Seeking Alpha as a personal hobby and to elicit feedback on specific ideas and topics, help organize my thinking, and connect with intelligent people.